Literature DB >> 25598107

Hirschsprung disease in the premature newborn: a population based study and 40-year single center experience.

Earl C Downey1, Elizabeth Hughes1, Angelica R Putnam2, Henry J Baskin3, Michael D Rollins4.   

Abstract

BACKGROUND/
PURPOSE: Understanding of Hirschsprung disease (HD) in premature newborns (PHD) is anecdotal. We have sought in this study to identify the demographic and clinical features of PHD.
METHODS: All patients with HD 1970-2011 treated at our tertiary care children's hospital were identified. Patients with biopsy confirmed HD and EGA <37weeks were selected for further review. Prenatal and birth data, demographics, clinical signs, radiologic and pathologic data, and operative interventions were examined. The occurrence of PHD was observed using data from the Utah Department of Health database 1997-2011.
RESULTS: 404 patients with HD from 1970 to 2011 were treated. Twenty-seven (6.7%) had PHD. Mean birth weight in PHD was 2196grams and mean gestational age 34 (range 29-36)weeks. Seven patients had Down syndrome. Nonchromosomal anomalies occurred in 25%. Median time from birth to biopsy diagnosis was 42days (range 2-316days). The most common presenting signs were abdominal distension and bilious emesis. The HD incidence in Utah for all births was 1/4322 (0.023%) and for premature infants 1/3885 (0.027%).
CONCLUSIONS: PHD are similar to term infants with HD. Diagnosis of HD is often delayed in premature newborns, and associated anomalies are more common.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Hirschsprung disease; Prematurity

Mesh:

Year:  2014        PMID: 25598107     DOI: 10.1016/j.jpedsurg.2014.10.013

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  6 in total

Review 1.  Established and emerging concepts in Hirschsprung's-associated enterocolitis.

Authors:  Ankush Gosain
Journal:  Pediatr Surg Int       Date:  2016-01-19       Impact factor: 1.827

Review 2.  Hirschsprung disease - integrating basic science and clinical medicine to improve outcomes.

Authors:  Robert O Heuckeroth
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2018-01-04       Impact factor: 46.802

3.  Epidemiology of Hirschsprung disease in California from 1995 to 2013.

Authors:  Jamie E Anderson; Melissa A Vanover; Payam Saadai; Rebecca A Stark; Jacob T Stephenson; Shinjiro Hirose
Journal:  Pediatr Surg Int       Date:  2018-10-15       Impact factor: 1.827

4.  One-stage transanal endorectal pull-through for Hirschsprung disease: experience with 229 neonates.

Authors:  Yanan Zhang; Zhaozhou Liu; Shuangshuang Li; Shen Yang; Jiawei Zhao; Ting Yang; Siqi Li; Yongwei Chen; Weihong Guo; Dawei Hou; Yingzi Li; Jinshi Huang
Journal:  Pediatr Surg Int       Date:  2022-08-28       Impact factor: 2.003

5.  Hirschsprung's disease in the UK and Ireland: incidence and anomalies.

Authors:  T J Bradnock; M Knight; S Kenny; M Nair; G M Walker
Journal:  Arch Dis Child       Date:  2017-03-09       Impact factor: 3.791

6.  Postoperative enterocolitis assessment using two different cut-off values in the HAEC score in Hirschsprung patients undergoing Duhamel and Soave pull-through.

Authors:  Afnandito Valeno Risky Sukarelawanto; Azmi Ritana; Naisya Balela; Wayan Julita Krisnanti Putri; Dian Nirmala Sirait; Vincentia Meta Widya Paramita; Andika Purba Sasmita; Andi Dwihantoro; Akhmad Makhmudi
Journal:  BMC Pediatr       Date:  2020-10-02       Impact factor: 2.125

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.